Leading pharmaceutical biotechnology (00399.HK) issued 149 million shares due to the conversion of convertible bonds.

The Zhongtong Finance and Economics APP News, leading pharmaceutical and biotechnology company (00399.HK) announced, according to the conversion rights of convertible bonds issued on October 25, 2013, issued 149 million shares of convertible shares on July 15, 2025, with a principal amount of 30 million Hong Kong dollars.